MAPT and Alzheimer disease: The study of this issue is crucial, since the treatment of neuropsychiatric disorders in AD is essential to the well-being of the patients, and it may even lead to cognitive improvements by acting on beta-amyloid (Aβ) pathology and tau hyperphosphorylation, characteristic hallmarks of AD, despite the need of more studies to clarify these mechanisms [4].